BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 32283571)

  • 1. CASC5 is a potential tumour driving gene in lung adenocarcinoma.
    Cui Y; Zhang C; Ma S; Guo W; Cao W; Guan F
    Cell Biochem Funct; 2020 Aug; 38(6):733-742. PubMed ID: 32283571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis.
    Zhu Y; Bo H; Chen Z; Li J; He D; Xiao M; Xiang L; Jin L; Zhou J; Gong L; Zhou Y; Zhou M; Xiong W; Xing X; Li R; Cao K
    Aging (Albany NY); 2020 Nov; 12(21):21904-21922. PubMed ID: 33147570
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Mizuno K; Tanigawa K; Nohata N; Misono S; Okada R; Asai S; Moriya S; Suetsugu T; Inoue H; Seki N
    Cells; 2020 Sep; 9(9):. PubMed ID: 32932948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-106b-5p inhibits growth and progression of lung adenocarcinoma cells by downregulating IGSF10.
    Ling B; Liao X; Tang Q; Ye G; Bin X; Wang J; Pang Y; Qi G
    Aging (Albany NY); 2021 Jul; 13(14):18740-18756. PubMed ID: 34351868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCG18/miR-34a-5p/HMMR axis accelerates the progression of lung adenocarcinoma.
    Li W; Pan T; Jiang W; Zhao H
    Biomed Pharmacother; 2020 Sep; 129():110217. PubMed ID: 32559619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
    Feng H; Zhang Z; Qing X; French SW; Liu D
    Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-139-5p Targeting CCNB1 Modulates Proliferation, Migration, Invasion and Cell Cycle in Lung Adenocarcinoma.
    Bao B; Yu X; Zheng W
    Mol Biotechnol; 2022 Aug; 64(8):852-860. PubMed ID: 35181869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
    Huang Y; Chen D; Bai Y; Zhang Y; Zheng Z; Fu Q; Yi B; Jiang Y; Zhang Z; Zhu J
    BMC Cancer; 2024 Apr; 24(1):452. PubMed ID: 38605349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TFAP2A-induced SLC2A1-AS1 promotes cancer cell proliferation.
    Cui Y; Zhang C; Ma S; Guan F
    Biol Chem; 2021 May; 402(6):717-727. PubMed ID: 33580997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8.
    Hu C; Wu J; Wang L; Liu X; Da B; Liu Y; Huang L; Chen Q; Tong Y; Jiang Z
    Pathol Res Pract; 2021 Jul; 223():153459. PubMed ID: 33971546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic expression analysis of the CELSR family reveals the importance of CELSR3 in human lung adenocarcinoma.
    Li Y; Zhu L; Hao R; Li Y; Zhao Q; Li S
    J Cell Mol Med; 2021 May; 25(9):4349-4362. PubMed ID: 33811453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma.
    Zhou Q; Li D; Zheng H; He Z; Qian F; Wu X; Yin Z; Bao PT; Jin M
    Thorac Cancer; 2021 Oct; 12(19):2526-2536. PubMed ID: 34453499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma.
    Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z
    Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-9-5p Promotes Lung Adenocarcinoma Cell Proliferation, Migration and Invasion by Targeting ID4.
    Zhu K; Lin J; Chen S; Xu Q
    Technol Cancer Res Treat; 2021; 20():15330338211048592. PubMed ID: 34723712
    [No Abstract]   [Full Text] [Related]  

  • 18. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
    Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.
    Yu L; Qiao R; Xu J; Han B; Zhong R
    Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
    Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
    IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.